Results 1 to 10 of about 51,241 (251)

Intravenous Thrombolysis in Patients on Direct Oral Anticoagulants: Analysis of the Get With The Guidelines Stroke Registry [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Intravenous thrombolysis for acute ischemic stroke (AIS) is a proven effective treatment. Whether thrombolysis in patients with AIS with recent direct oral anticoagulant (DOAC) use is safe and efficacious is not well established.
Shadi Yaghi, Liqi Shu, Eva A. Mistry, Opeolu Adeoye, Lee Schwamm, Steven Messe, Mitchell S. V. Elkind, Malik Ghannam, Adam de Havenon, Karen Furie, Ying Xian, Christopher Streib, Runqi Wangqin, Nils Henninger, Jeffrey L. Saver, Eric E. Smith   +15 more
doaj   +2 more sources

Meta-Analysis of Predictive Role of Early Neurological Deterioration after Intravenous Thrombolysis

Emergency Medicine International, 2022
With the popularization of intravenous thrombolysis, more and more people use intravenous thrombolysis to treat related diseases, but problems also arise. There are still a considerable number of patients with early disease after thrombolytic therapy not
Haiwei Jiang, Jing Zuo, Dan Wang, Yi Huang, Chang Gao, Yue Wan   +5 more
doaj   +1 more source

Trends in stroke thrombolysis rate in Bosnia and Herzegovina: a hospital-based observation study [PDF]

Medicinski Glasnik, 2023
Aim To assess trends in thrombolysis rates and door-to-needle times in University Hospital Mostar. Methods Data from the University Hospital Mostar Registry were used.
Marija Bender, Stjepan Čović, Matea Baranik, Sandra Lakičević, Inge Klupka-Sarić   +4 more
doaj   +1 more source

Analysis of influencing factors of early neurological improvement after intravenous rt-PA thrombolysis in acute anterior circulation ischemic stroke

Frontiers in Neurology, 2022
Background and objectiveIt has been widely reported that Early neurological improvement (ENI) after rt-PA intravenous thrombolysis contributes to a good long-term prognosis in patients experiencing acute ischemic stroke (AIS).
Zhang Xiufu, Liang Ruipeng, Zhou Jun, Li Yonglong, Wang Yulin, Zeng Jian, Chen Xianglin, Shen Lan, Zhang Zuowen   +8 more
doaj   +1 more source

Clinical safety and possible efficacy of tirofiban in combination with intravenous thrombolysis by recombinant tissue plasminogen activator for early treatment of capsular warning syndrome (CWS)

Frontiers in Neuroscience, 2022
The purpose of this study was to assess the efficacy and safety of the combination of tirofiban with intravenous thrombolysis (IVT) in treating patients with capsular warning syndrome (CWS) who failed to respond to the treatment of intravenous ...
Yunzhu Liu, Shiyong Li, Dongdong Hao, Zhongping Zhang, Yongxin Yi, Jiayang Fang, Weizhi Lin, Min Zhang   +7 more
doaj   +1 more source

Intravenous thrombolysis and platelet count [PDF]

Neurology, 2018
In the article “Intravenous thrombolysis and platelet count” by Gensicke et al.,1 there were a …
Gensicke, H, Al Sultan, AS, Strbian, D, Hametner, C, Zinkstok, SM, Moulin, S, Bill, O, Zini, A, Padjen, V, Kagi, G, Pezzini, A, Seiffge, DJ, Traenka, C, Raty, S, Amiri, H, Zonneveld, TP, Lachenmeier, R, Polymeris, A, Roos, YB, Gumbinger, C, Jovanovic, DR, Curtze, S, Sibolt, G, Vandelli, L, Ringleb, PA, Leys, D, Cordonnier, C, Michel, P, Lyrer, PA, Peters, N, Tatlisumak, T, Nederkoorn, PJ, Engelter, ST   +32 more
openaire   +6 more sources

Efficacy, Influencing Factors, and Safety of Alteplase Intravenous Thrombolysis in Patients with Acute Ischemic Stroke Combined with Atrial Fibrillation

Journal of Chemistry, 2022
Ischemic stroke is the most common type of stroke. Intravenous thrombolytic therapy with alteplase is currently the most effective method to improve the prognosis of patients with acute cerebral infarction.
Yongyin Zhang, Haoye Cai, Hao Shu, Ruqian He, Xuerong Huang, Xiaoyi Song   +5 more
doaj   +1 more source

Successful Intravenous Thrombolysis in Ischemic Stroke Caused by Tuberculous Meningitis: A Case Report

Frontiers in Neurology, 2021
Tuberculous meningitis (TBM) has a variety of clinical manifestations and complications, and ischemic stroke is a common complication of TBM. However, there is no established prevention or treatment for stroke associated with TBM, and the safety and ...
Xinke Peng, Xiaomei Wu, Lingling Lv, Qile Xiao, Yajing Zhan, Chunyu Wang, Hainan Zhang   +6 more
doaj   +1 more source

Clinical comparison of intravenous thrombolysis and bridging artery thrombectomy in hyperacute ischemic stroke with unknown time of onset

Archives of Medical Science, 2021
Introduction The aim of the study was to explore the clinical efficacy and safety of intravenous thrombolysis and bridging artery thrombectomy for hyperacute ischemic stroke with unknown onset time.
Bai Qingke, Zheng Ping, Zhang Jianying, Zhao Zhenguo   +3 more
doaj   +1 more source

Relationship between rLMC score, peripheral blood ACE, SDF-1α and prognosis of acute anterior circulation cerebral infarction after intravenous thrombolysis

Zhongguo linchuang yanjiu, 2023
Objective To explore the relationship between regional leptomeningeal collateral (rLMC) score, peripheral blood angiotensin-converting enzyme (ACE), matrix-derived growth factor (SDF)-1α levels, and the prognosis of acute anterior circulation ischemic ...
LI Binglong*, GAO Xia, LI Yan
doaj   +1 more source